CANCER:

Hormone Receptor Negative Breast Cancer

Related cancers:

‹

Breast Cancer (1834)

HER2 Negative Breast Cancer (373)

HER2 Positive Breast Cancer (360)

Hormone Receptor Positive Breast Cancer (286)

Triple Negative Breast Cancer (274)

Estrogen Receptor Positive Breast Cancer (187)

Male Breast Cancer (9)

Breast Cancer (1834)

HER2 Negative Breast Cancer (373)

HER2 Positive Breast Cancer (360)

Hormone Receptor Positive Breast Cancer (286)

Triple Negative Breast Cancer (274)

Estrogen Receptor Positive Breast Cancer (187)

Male Breast Cancer (9)

›

HER-2 overexpression HER-2 overexpression	Hormone Receptor Negative Breast Cancer Hormone Receptor Negative Breast Cancer	HER-2 overexpression HER-2 overexpression	Hormone Receptor Negative Breast Cancer Hormone Receptor Negative Breast Cancer	trastuzumab + lapatinib Sensitive: A1 - Approval	trastuzumab + lapatinib Sensitive: A1 - Approval
HR negative HR negative	Hormone Receptor Negative Breast Cancer Hormone Receptor Negative Breast Cancer	HR negative HR negative	Hormone Receptor Negative Breast Cancer Hormone Receptor Negative Breast Cancer	TCHP Sensitive: C3 – Early Trials	TCHP Sensitive: C3 – Early Trials
HER-2 overexpression HER-2 overexpression	Hormone Receptor Negative Breast Cancer Hormone Receptor Negative Breast Cancer	HER-2 overexpression HER-2 overexpression	Hormone Receptor Negative Breast Cancer Hormone Receptor Negative Breast Cancer	trastuzumab + pertuzumab Sensitive: C3 – Early Trials	trastuzumab + pertuzumab Sensitive: C3 – Early Trials
HER-2 amplification + HER-2 R157W HER-2 amplification + HER-2 R157W	Hormone Receptor Negative Breast Cancer Hormone Receptor Negative Breast Cancer	HER-2 amplification + HER-2 R157W HER-2 amplification + HER-2 R157W	Hormone Receptor Negative Breast Cancer Hormone Receptor Negative Breast Cancer	pyrotinib Sensitive: C4 – Case Studies	pyrotinib Sensitive: C4 – Case Studies